New Member FireCyte Therapeutics
 Welcome FireCyte Therapeutics to NSIV! FireCyte offers to target microglia which paves the way for the discovery and development of first-in-class therapeutics that mitigate both harmful neuroinflammatory disease processes and promote neuroprotection. FireCyte is led by Bill Yelle, CEO, and Jon Levenson, CSO.
|
|
 BioLumic Inc. (“BioLumic”) announced the closing of a $13.5-million Series B funding round that will be used to accelerate commercial growth for its cutting-edge, patented agricultural technology that harnesses the power of ultraviolet light to improve plant productivity.
|
|
 Sofia Malferrari of Bioenzymatic Fuel Cells (BeFC) appeared on a recent episode of the podcast RadioEntrepeneurs
with Jeffrey Davis. In the podcast, Sofia discussed in detail BeFC's eco-friendly fuel-cell batteries for low-power applications. BeFC is a VIE that is expanding its operations from France to the U.S.
|
|
Keeping Up NSIV With Graduates
 seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announced a partnership with Element Biosciences Inc., developer of the Element AVITI™ System.
|
|
What's Going On?
 MassBio Hub Open House Lunch
July 20th, 12PM-2PM
Interested in learning more about how you can host your next event at the MassBioHub? Join us for an Open House and hear all about the Hub's offerings and audio-visual capabilities. You will enjoy a complimentary lunch provided by our caterer, meet the production team who can customize your hybrid or virtual event, and tour the entire facility to see its various room configurations. This state-of-the-art flexible use space can accommodate many types of events and meetings for 2 - 150 people.
|
|
|
|
|
